Top pharma firms in S. Korea spend over $72.13 million each in H1 for R&D

Seoul, Aug 23 (IANS) South Korea's major pharmaceutical companies spent around 100 billion won ($72.13 million) each in the first half for the research and development (R&D) of new drugs, data showed on Sunday, in an apparent bid to secure future growth engines.